Syringes Market Size is Anticipated to Acquire USD 6.9 billion by 2031

Posted by Kaustubh Ravan on February 5th, 2024

The syringes market was worth US$ 4 billion in Europe in 2021. From 2022 to 2031, it is projected to grow at a CAGR of 5.6%. The market for syringes in Europe is estimated to reach US$ 6.9 billion by 2031. COVID-19 has increased global pandemic preparedness. A rapid and effective response to future health crises can be ensured by stockpiling essential medical supplies, such as syringes.

New product launches are helping leading players gain an edge over competitors and create new revenue streams. In September 2021, Medtronic plc announced the launch of a new syringe with the ability to deliver osteoinductive DBM into the surgical site. Additionally, prominent players could expand their production capacities in a bid to meet consumer requirements.

Download Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84826

Global Syringes Market: Key Players

Syringes are a consolidated market, with a few major vendors controlling most of the market. Research & development is a top priority for key firms, especially those involved in environmental protection. Mergers & acquisitions and expanding product portfolios are key strategies key players adopt.

Baxter International Inc.
B. Braun Melsungen AG
Becton, Dickinson and Company (BD)
Cardinal Health
Gerresheimer AG
Medtronic plc
Nipro Corporation
Gerresheimer AG
SCHOTT AG
ICU Medical Inc.
Terumo Corporation
Teleflex Incorporated
Vitrex Medical A/S (CTI Group

Key Developments

In October 2023, ClorDiSys Solutions, Inc., headquartered in Branchburg, NJ, hosted its first European conference on Prefilled Syringes and Injection Devices, where chlorine dioxide gas technology was demonstrated. As a result of the health and environmental concerns associated with ethylene oxide gas, Pure CDTM has now been introduced into Europe.
In November 2023, Alvotech, the world’s largest biotech company that develops and manufactures biosimilars, The JAMP Pharma Group (“JAMP Pharma”), announced that Health Canada granted AVT04 marketing authorization as an Alvotech biosimilar. There will be a marketing campaign for AVT04, marketed under the name JamtekiTMThere will be a marketing campaign for AVT04, marketed under the name JamtekiTM.

Global Syringes Market: Segmentation

Product Type

- General Purpose Syringe
- Specialized Syringes

- - Insulin
  - Others
- Smart Syringes
Application
- Therapeutics
- Diagnostics
- Immunization
- Others
Usage
- Disposable
  - Conventional Syringe
  - Safety Syringes
- Reusable
Material
- Plastic
  - PP
  - LDPE
  - HDPE
  - Others
- Glass
End-user

- Hospitals & Clinics
- Independent Diagnostic Laboratories
- Blood Banks
- Pharmaceuticals & Biotechnology Companies
- Veterinary Facilities
- Others

About Transparency Market Research

Transparency Market Research, a global market research company registered in Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. Our experienced Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll-Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Email: sales@transparencymarketresearch.com

Follow Us: LinkedIn| Twitter| Blog | YouTube